---
figid: PMC3587990__ijms-14-02334f2
figlink: /pmc/articles/PMC3587990/figure/f2-ijms-14-02334/
number: F2
caption: Scheme of survival signaling cascade by receptor tyrosine kinases via PI3K/AKT
  mediated survival. The binding of a ligand (Growth Factor) to its receptor triggers
  intrinsic tyrosine kinase phosphorylation, subsequently activating IRS and PI3K.
  Activated PI3K generates phosphatidylinositol-3,4,5-triphosphate, which recruits
  phosphatidylinositol-dependent kinase (PDK) and AKT serine/threonine kinase at the
  plasma membrane, resulting in phosphorylation of AKT. After phosphorylation, activated
  AKT inactivates other apoptogenic factors, Bad (a pro-apoptotic protein, which in
  its non-phosphorylated state, promotes apoptosis) and caspase 9. AKT also activates
  mTOR by phosphorylation. The transcription factor NF-κB can lead to transactivation
  of a wide range of antiapoptotic NF-κB target genes (e.g., Bcl-XL and Bcl-2). AKT
  also phosphorylates MDM2 (murine double minute protein), which in turn inhibits
  p53 action. On the other hand, cell survival and proliferative signals are mediated
  by the Ras/Raf pathway (). Receptor tyrosine kinase phosphorylation also activates
  the GRB/SOS2 (Growth factor receptor-bound protein 2/Son of Sevenless, adaptor proteins),
  which in turn activates Ras (Rous sarcoma protein). Then, Ras activates Raf-1(Receptor
  activated factor-1) kinase, which subsequently activates the MEK and ERK, thereby
  regulating the survival, proliferation, migration and invasion of cancer.
pmcid: PMC3587990
papertitle: 'Cell Survival and Apoptosis Signaling as Therapeutic Target for Cancer:
  Marine Bioactive Compounds.'
reftext: Senthilkumar Kalimuthu, et al. Int J Mol Sci. 2013 Feb;14(2):2334-2354.
pmc_ranked_result_index: '65269'
pathway_score: 0.9626955
filename: ijms-14-02334f2.jpg
figtitle: Scheme of survival signaling cascade by receptor tyrosine kinases via PI3K/AKT
  mediated survival
year: '2013'
organisms:
- uncultured actinomycete
- Mus musculus
- Ecklonia cava
- Zyzzya fuliginosa
- Salinispora arenicola
- Streptomyces sp.
- Cystodytes dellechiajei
- Hyrtios erectus
- Haliclona sp.
- Streptomyces sp. 04
- PX clade
- Dicathais orbita
- Homo sapiens
- Bos taurus
ndex: cecd4d20-ded6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3587990__ijms-14-02334f2.html
  '@type': Dataset
  description: Scheme of survival signaling cascade by receptor tyrosine kinases via
    PI3K/AKT mediated survival. The binding of a ligand (Growth Factor) to its receptor
    triggers intrinsic tyrosine kinase phosphorylation, subsequently activating IRS
    and PI3K. Activated PI3K generates phosphatidylinositol-3,4,5-triphosphate, which
    recruits phosphatidylinositol-dependent kinase (PDK) and AKT serine/threonine
    kinase at the plasma membrane, resulting in phosphorylation of AKT. After phosphorylation,
    activated AKT inactivates other apoptogenic factors, Bad (a pro-apoptotic protein,
    which in its non-phosphorylated state, promotes apoptosis) and caspase 9. AKT
    also activates mTOR by phosphorylation. The transcription factor NF-κB can lead
    to transactivation of a wide range of antiapoptotic NF-κB target genes (e.g.,
    Bcl-XL and Bcl-2). AKT also phosphorylates MDM2 (murine double minute protein),
    which in turn inhibits p53 action. On the other hand, cell survival and proliferative
    signals are mediated by the Ras/Raf pathway (). Receptor tyrosine kinase phosphorylation
    also activates the GRB/SOS2 (Growth factor receptor-bound protein 2/Son of Sevenless,
    adaptor proteins), which in turn activates Ras (Rous sarcoma protein). Then, Ras
    activates Raf-1(Receptor activated factor-1) kinase, which subsequently activates
    the MEK and ERK, thereby regulating the survival, proliferation, migration and
    invasion of cancer.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - AKT3
  - NFKB1
  - AKT1
  - KRAS
  - BAD
  - HRAS
  - MAPK1
  - SOS1
  - MAPK3
  - SOS2
  - PTEN
  - NRAS
  - MAP2K2
  - MTOR
  - IKBKB
  - PIK3R3
  - PDK2
  - PIK3R6
  - RAF1
  - PIK3CB
  - PIK3CG
  - MAP2K1
  - PIK3CD
  - PIK3R4
  - PIK3R5
  - PIK3CA
  - MDM2
  - Tyrosine
  - Cancer
  - Lung cancer
  - Noonan syndrome
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Bad
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: IKKB
  symbol: IKK-beta
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PDK2
  symbol: PDK2
  source: hgnc_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Raf-1
  symbol: Raf-1
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
chemicals:
- word: Tyrosine
  source: MESH
  identifier: D014443
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3587990__F2
redirect_from: /figures/PMC3587990__F2
figtype: Figure
---
